Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR
The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour.
Canada's Spartan Bioscience Reemerges as Genomadix With Eye Toward Near-Patient COVID-19 Testing
The firm is now moving forward on COVID-19 molecular diagnostic clinical trials in the US with the hopes of obtaining FDA Emergency Use Authorization.
Spartan Bioscience to Sell Assets to Finance Firm Casa-Dea
Casa-Dea said that it aims to keep Spartan in Canada following the close of the transaction, which is expected later this month.
Spartan Bioscience Taps Cardinal Health as US Distributor of CYP2C19 Genotyping Assay
The new distribution partnership is for the US acute care market where, until now, Spartan was selling directly.
The Ottawa-based molecular diagnostics maker also plans to enter applied markets in the near term, and ultimately point-of-care infectious disease testing.